CIK 0001811115 · <br>Emerging growth company
Renalytix plc
Sign in to watch- Ticker
- RENXF
- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- FY end
- Jun 30
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 29 2071 0570
- Business address
- FINSGATE, 5-7 CRANWOOD STREET, LONDON, United Kingdom
- Former names
- Renalytix AI plc
Securities
- RENXF Common stock OTC
- RNLXY American depositary shares OTC
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results · Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 8-K/A Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- SC 13G/A Stake Amended Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Executive or director change · Shareholder vote results · Regulation FD disclosure
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- 25 Other Notification of Removal from Listing
- SC 13D/A Stake Beneficial Ownership Report
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Acquisition or sale completed · Results of operations · New debt or obligation · Delisting notice · Unregistered share sale · Other events
- 10-K Report Annual Report
- 8-K Event Delisting notice · Regulation FD disclosure
- 8-K Event Unregistered share sale · Regulation FD disclosure
Page 2 of 12 · 233 filings